Biomerica Inc revenue
Biomerica Inc's revenue was $4.5m in fiscal 2026, down 16.2% on the year before. Since fiscal 2011 ($4.9m) it has grown at a compound -0.6% a year. Over the last twelve months it was $4.3m.
Revenue history
| Fiscal year | 2011May 2011 | 2012May 2012 | 2013May 2013 | 2014May 2014 | 2015May 2015 | 2016May 2016 | 2017May 2017 | 2018May 2018 | 2019May 2019 | 2020May 2020 | 2021May 2021 | 2022May 2022 | 2023May 2023 | 2024May 2024 | 2025May 2025 | 2026May 2026 | LTMAug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 | 6 | 6 | 5 | 5 | 5 | 6 | 6 | 5 | 7 | 7 | 19 | 5 | 5 | 5 | 4 | 4 |
| Growth on the year before | — | +24.1% | +6.4% | −20.9% | −3.1% | +3.6% | +12.7% | −3.9% | −6.5% | +28.7% | +7.6% | +162.1% | −71.7% | +1.4% | −1.9% | −16.2% | — |
| Gross profit | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 0 | 3 | 0 | 1 | 0 | 0 | 0 |
| Gross margin | 31.1% | 37.8% | 37.5% | 32.6% | 31.1% | 29.7% | 34.9% | 31.5% | 24.8% | 26.0% | 5.1% | 15.8% | 8.4% | 11.3% | 9.4% | 8.1% | 0.9% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Clinical Lab | $2.7M | 61.4% | ▼ 14.1% |
| Contract Manufacturing | $891,000 | 20.0% | ▼ 16.7% |
| Over The Counte | $821,000 | 18.4% | ▼ 21.7% |
| Physicians Office | $9,000 | 0.2% | ▼ 18.2% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| North America | $1.5M | 32.9% | ▼ 11.6% |
| Asia | $1.4M | 31.6% | ▼ 18.0% |
| Europe | $1.1M | 25.1% | ▼ 13.9% |
| Middle East | $446,000 | 10.0% | ▼ 29.2% |
| South America | $15,000 | 0.3% | ▲ 87.5% |
From Biomerica Inc's 10-K filed August 31, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Biomerica Inc | $4.3m | -11.2% | -7.1% |
| Intelligent BIO Solutions Inc. | $4.2m | 38.1% | 39.0% |
| Cerenome, Inc. | $4.2m | -21.0% | 16.1% |
| Charming Medical Ltd | $4.8m | -22.7% | — |
| Neuraxis, Inc | $5.3m | 65.2% | 25.6% |
| Lucid Diagnostics Inc. | $5.4m | 24.9% | 90.1% |
Compare with peers
- Intelligent BIO Solutions Inc. revenue
- Cerenome, Inc. revenue
- Charming Medical Ltd revenue
- Neuraxis, Inc revenue
- Lucid Diagnostics Inc. revenue
Head to head: BMRA vs INBSBMRA vs CNSYBMRA vs MCTA
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies